Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study

BACKGROUND: Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often employed, but higher doses may be necessary to control large tumors. Previously, we...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Radiat Oncol
Glavni autori: Miyakawa, Akifumi, Shibamoto, Yuta, Baba, Fumiya, Manabe, Yoshihiko, Murai, Taro, Sugie, Chikao, Yanagi, Takeshi, Takaoka, Taiki
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5594596/
https://ncbi.nlm.nih.gov/pubmed/28893300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0888-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items